StonvexLoading…
StonvexStonvexStonvexCore line items from DJT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.68M | $3.62M | $4.13M | $1.47M |
Operating Income | $-573.04M | $-186.04M | $-15.97M | $-23.25M |
Net Income | $-712.34M | $-400.86M | $-58.19M | $50.52M |
EPS (Diluted) | $-2.80 | $-2.36 | $-0.67 | $0.58 |
Total Assets | $2.63B | $938.29M | $3.36M | $300.50M |
Total Liabilities | $982.82M | $24.70M | $70.13M | $33.52M |
Cash & Equivalents | $134.56M | $170.24M | $2.57M | $989.00 |
Free Cash Flow OCF − CapEx | $14.18M | $-66.02M | $-9.74M | $-24.29M |
Shares Outstanding | 276.72M | 220.66M | 87.50M | 87.50M |